| SATELLITE
SYMPOSIA |
The Sponsored Satellite Symposia are designed to present the most
recent developments in the fields of emerging technologies and therapeutic
innovations which are likely to improve or change current and future
medical practices.
 |
| |
| |
|
| |
Monday,
April 14, 2003 - 17.50 - 19.15
 HPV
Vaccines - Future Trends in HPV Disease Prevention
Chairs:
E. Franco (Canada), J. Monsonego (France)
• Type
distribution of HPV in cervical cancer
• HPV vaccines,
development, overview
• GSK HPV vaccine update
•
Efficacy endpoints for HPV clinical trials
Faculty: X. Bosch, E. Franco, J. Monsonego
and others tbd
Tuesday, April 15,
2003 - 17.30 - 19.00
HSV
Vaccines - Looking into the Future
Chair:
B. Belshe (USA)
• Epidemiology of HSV in Europe
and the US
• HSV vaccines: prospects and challenges
• Modeling the impact of HSV vaccination on public health
• Design of phase III HSV vaccine efficacy study
Faculty: B. Belshe (USA), J.J. Smith (France),
G. Garnett (UK), and others tbd
Tuesday,
April 15, 2003 - 11.30 - 13.00
New
Strategies to Prevent Genital Herpes Transmission
• Diagnosis and management options for genital herpes
• Preventing genital herpes transmission
• Transmission
of HSV to neonates
Faculty: R. Patel (UK), J.E. Malkin (France)
and others tbd
|
| |
|
| |
|
| |
Sunday,
April 13, 17.30 – 19.00
HPV
Testing Comes of Age
HPV Primary Screening with Cytology: the DNA Pap
• Clinical trial data from France, Germany,
Italy, Switzerland and UK
• Guidelines for clinicians: the HPV positive woman
• Single cervical sample – multiple women’s health
tests |
| |
|
| |
|
| |
Sunday,
April 13, 2003 - 11.30 – 13.00
Update
on the Management of Genital Warts
Chair: J. Monsonego (France)
•
The epidemiology on HPV infection in Europe
• Mode of
action of Imiquimod and its potential for the treatment of STIs
• Aldara in the treatment of genital warts
• Genital
warts and psychological issues.
Faculty: X. Bosch (Spain), M. Stanley (UK),
S. Garland (Australia),
C. O’Mahony (UK)
Wednesday,
April 16, 2003 - 11.30 – 13.00
Immune
Response Modification, the emerging future for the treatment of
HPV Related Cevical Disease
|
| |
|
| |
|
| |
Monday,
April 14, 2003 - 11.45 - 13.00
ThinPrep®
in an Organised Cervical Screening Programme
Chair: E. Mc Googan (UK) |
| |
|
| |
|
| |
Tuesday,
April 15, 2003 - 17.30 - 19.00
Practical
Aspects of Molecular Diagnostics Applied to Women's Health
•
Liquid cytology and molecular diagnostics applications
• The Roche HPV programme: from science to practice
• Future
molecular applications in women's health
Faculty: J. Kornegay (USA), K.U. Petry (Germany)
and others tbd
|
| |
|
| |
|
| |
Tuesday,
April 15, 2003 - 11.30 – 13.00
Symposium
Electric-optical Real Time Screening Methods
• Rationale for real time screening
• TruScreen
technology overview
• Review of sponsored studies
Faculty: N. Hacker (Australia), A. Singer
(UK), G. De Palo (Italy), T. Cox (USA) |
| |
|
| |
|
| |
Tuesday,
April 15, 2003 - 11.30 – 13.00
New
Advances in HPV Testing |
| |
|
|
| |
 Sponsored
by
AVENTIS
PASTEUR
http://www.aventis-pasteur-msd.com
|
| |
Tuesday,
April 15, 2003 - 15.30 - 17.30
Advances
and Perspectives on HPV Vaccines
|
| |
|
|
| |
|
| |
Wednesday,
April 16, 2003 - 11.30 - 13.00
Implementation
of New Technologies for Cervical Cancer
• Liquid based cytology - optimizing the sampling process
• FocalPoint GS: location guided screening using SurePath
specimen Concepts and current data
• Combined uses of
new technologies in primary screening for cervical cancer
•
Located guided screening implementation in a european laboratory
Faculty: G. Bigras (Switzerland), D. C. Wilbur
(USA),
P. Vassilakos (Switzerland), H. Neumann (Germany) |
| |
|
|
| |
|
| |
Wednesday,
April 16, 2003 - 11.30 - 13.00
HPV
Genotyping: a New Approach to Disease Management? |
| |
|
EUROGIN.COM
Sponsored
by